Insider · CIK 0001872543
Medmira Capital Ltd.
Reports to the SEC for 1 company · NANSHAN SHENZHEN, F4
Transactions
5
Companies
1
Filings
2
CIK
0001872543
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-09-15 | HCWBHCW Biologics Inc.J Other | — |
| 2021-07-22 | HCWBHCW Biologics Inc.C Conversion | — |
| 2021-07-22 | HCWBHCW Biologics Inc.C Conversion | — |
| 2021-07-22 | HCWBHCW Biologics Inc. · Series B Redeemable Preferred StockC Conversion | — |
| 2021-07-22 | HCWBHCW Biologics Inc. · Series C Redeemable Preferred StockC Conversion | — |
Recent filings
- 4Medmira Capital Ltd.0001209191-21-056677SEC(opens sec.gov)
- 4Medmira Capital Ltd.0001209191-21-048086SEC(opens sec.gov)
Companies
Address
16F BEIKE BUILDING 59 GAOXIN NANJIU RD
NANSHAN SHENZHEN, F4, 51805